Loss of STARD7 Triggers Metabolic Reprogramming and Cell Cycle Arrest in Breast Cancer
Advanced Science · 2025
DOI: 10.1002/advs.202503022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Ewelina Dondajewska und 18 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cancer Biology, Liège, Belgium. Hauptthemen laut MEDLINE: Breast Neoplasms, Cell Cycle Checkpoints, Carrier Proteins, Cellular Reprogramming. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: WELBIO, Belgian Foundation against Cancer.
Abstract (Originalsprache)
Cancer cells adapt their metabolism to support aberrant cell proliferation. However, the functional link between metabolic reprogramming and cell cycle progression remains largely unexplored. Mitochondria rely on the transfer of multiple lipids from the endoplasmic reticulum (ER) to their membranes to be functional. Several mitochondrial‐derived metabolites influence cancer cell proliferation by modulating the epigenome. Here, the loss of STARD7, a lipid transfer protein whose expression is enhanced in breast cancer, is shown to lead a metabolic reprogramming characterized by the accumulation of carnitine derivatives and S‐Adenosyl‐L‐methionine (SAM). Elevated SAM levels cause the increase of H3K27 trimethylation on many gene promoters coding for candidates involved in cell cycle progression. Likewise, STARD7 deficiency triggers cell cycle arrest and impairs ERα‐dependent cell proliferation. Moreover, EGFR signaling is also impaired in triple negative breast cancer cells lacking STARD7, at least due to deregulated EGFR trafficking to lysosomes. Therefore, mitochondria rely on STARD7 to support cell cycle progression in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cancer Biology, Liège, Belgium.
- GIGA Cancer, GIGA, University of Liege, CHU, Sart-Tilman, Liège, 4000, Belgium.
- Department of Medical Biotechnology, Poznan University of Medical Sciences (PUMS), Poznan, Poland.
- GIGA Flow Cytometry and Cell Imaging Platform, University of Liege, Liege, Belgium.
- Laboratory of Cancer Signaling, Liège, Belgium.
- WELBIO department, WEL Research Institute, avenue Pasteur, 6, 1300, Wavre, Belgium.
ORCID-Profile: Alain Chariot
Förderung
- WELBIO
- Belgian Foundation against Cancer
Zitieren
APA
Dondajewska, E., Allepuz-Fuster, P., Maurizy, C., Hego, A., Ormenese, S., Lion, Q., Blomme, A., Close, P., Lavergne, A., Karim, L., Thiry, M., Nemazanyy, I., Krishnankutty, R., Marques, J., von Kriegsheim, A., Henneman, N. F., Panasyuk, G., Shostak, K., & Chariot, A. (2025). Loss of STARD7 Triggers Metabolic Reprogramming and Cell Cycle Arrest in Breast Cancer. Advanced Science. https://doi.org/10.1002/advs.202503022
Vancouver
Dondajewska E, Allepuz-Fuster P, Maurizy C, Hego A, Ormenese S, Lion Q, et al. Loss of STARD7 Triggers Metabolic Reprogramming and Cell Cycle Arrest in Breast Cancer. Advanced Science. 2025. doi:10.1002/advs.202503022
BibTeX
@article{Dondajewska2025,
author = {Dondajewska, Ewelina and Allepuz-Fuster, Paula and Maurizy, Chloé and Hego, Alexandre and Ormenese, Sandra and Lion, Quentin and Blomme, Arnaud and Close, Pierre and Lavergne, Arnaud and Karim, Latifa and Thiry, Marc and Nemazanyy, Ivan and Krishnankutty, Roopesh and Marques, Jair and von Kriegsheim, Alex and Henneman, Nathaniel F and Panasyuk, Ganna and Shostak, Kateryna and Chariot, Alain},
title = {Loss of STARD7 Triggers Metabolic Reprogramming and Cell Cycle Arrest in Breast Cancer},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202503022}
}
EUVIMED